APC TARGETING TECHNOLOGY

Welcome to the Brand page for “APC TARGETING TECHNOLOGY”, which is offered here for Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancer;.

Its status is currently believed to be active. Its class is unavailable. “APC TARGETING TECHNOLOGY” is believed to be currently owned by “CELLDEX THERAPEUTICS, INC.”


Owner:
CELLDEX THERAPEUTICS, INC.
Owner Details
Description:
Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancer;
Categories: VACCINES